Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
theMusic1d
How TYDE’s Years-Long Struggle With The Medical System Led To Their New Single, ‘Let The Dust Fall’
Brisbane’s female-fronted 8-piece known for their genre-bending style, TYDE, are back. And they’ve got something to say.
The Pharma Letter1d
Swiss approval for LEO Pharma’s Anzupgo
The indication is for the treatment of moderate to severe chronic hand eczema (CHE) in adults who have had an inadequate ...
LEO Pharma’s Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland
Anzupgo is the first topical pan-Janus kinase (JAK) inhibitor to be approved in Switzerland specifically for moderate to ...
Yahoo5d
Woman shares 'ordeal' of steroid cream withdrawal
A Jersey woman has been sharing her experience of Topical Steroid Withdrawal (TSW) to raise awareness of the difficulties ...
Hosted on MSN5d
What is Pityriasis Alba and How Is It Treated?
It may also happen if you use too much topical corticosteroids when treating eczema. This can cause areas of patchy rash to ...